Dexmedetomidine - Important Safety Information from Marketing Authorisation Holders of products containing dexmedetomidine as approved by the HPRA (16.06.22)

Notice type: 3rd Party Publications

Date: 20/06/2022

Important Safety Information from Marketing Authorisation Holders of products containing Dexmedetomidine: Increased risk of mortality in intensive care unit (ICU) patients ≤65 years

Important Safety Information – products containing dexmedetomidine